This is not the most recent version of the article. View current version (16 MAY 2012)

Intervention Protocol

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

  1. C Lafuente-Lafuente,
  2. S Mouly,
  3. MA Longas-Tejero,
  4. JF Bergmann

Editorial Group: Cochrane Heart Group

Published Online: 18 OCT 2004

DOI: 10.1002/14651858.CD005049

How to Cite

Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Bergmann JF. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation (Protocol). Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD005049. DOI: 10.1002/14651858.CD005049.

Author Information

*Dr Carmelo Lafuente-Lafuente, Praticien Attache, Service de Médecine Interne A, Hôpital Lariboisière, 2, rue ambroise Paré, Paris, 75010, FRANCE. c.lafuente@nodo3.net.

Publication History

  1. Published Online: 18 OCT 2004

SEARCH

This is not the most recent version of the article. View current version (16 MAY 2012)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the effect of long-term treatment with antiarrhythmic drugs in patients who have recovered sinus rhythm after having atrial fibrillation, to reduce death, stroke and embolism, drug adverse effects and recurrence of atrial fibrillation.

Primary aim is to assess the effects of any antiarrhythmic drugs compared with no antiarrhythmic drugs treatment, no treatment, placebo, or treatment for rate control. If several antiarrhythmic drugs appear to be effective the secondary aim will be to assess which is more effective.